With the exclusion of the liver where the amount declines upon malignant transformation, TRPM8 mRNA rises in several types of tumors with groups of bladder, breast, kidney and lung cancer samples characterized by particularly high expression of the channel (Fig. 1a). Here, TRPM8 is linked to lung cancer.